source name	characteristics[organism]	characteristics[organism part]	characteristics[age]	characteristics[developmental stage]	characteristics[sex]	characteristics[ancestry category]	characteristics[disease]	characteristics[phenotype]	characteristics[cell type]	characteristics[cell line]	characteristics[enrichment process]	characteristics[biological replicate]	assay name	comment[fractionation method]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[dissociation method]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters].1	comment[modification parameters].2	comment[modification parameters].3	comment[file uri]	comment[data file]	Material Type	Factor Value[compound]	factor value[enrichment process]
PXD000612-Sample-47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	run 202	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH11.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH11.raw	cell	EGF	no enrichment
PXD000612-Sample-47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	run 203	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH3.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH3.raw	cell	EGF	no enrichment
PXD000612-Sample-47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	run 204	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH4.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH4.raw	cell	EGF	no enrichment
PXD000612-Sample-47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	run 205	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH5.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH5.raw	cell	EGF	no enrichment
PXD000612-Sample-47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	run 206	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH6.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH6.raw	cell	EGF	no enrichment
PXD000612-Sample-47	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	epithelial cell	HeLa-S3	no enrichment	4	run 207	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	not applicable	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH8.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH8.raw	cell	EGF	no enrichment
